Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
54
CLMT Quote, Financials, Valuation and Earnings
Last price:
$16.03
Seasonality move
:
10.37%
Day range:
$15.40 - $16.50
52-week range:
$7.68 - $25.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.33x
P/B ratio:
--
Volume:
706.2K
Avg. volume:
1.2M
1-year change:
1.19%
Market cap:
$1.4B
Revenue:
$4.2B
EPS (TTM):
-$4.00
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | $3.1B | $4.7B | $4.2B | $4.2B | |
| Revenue Growth (YoY) | -34.31% | 38.79% | 48.87% | -10.78% | 0.2% | |
| Cost of Revenues | $2.2B | $3B | $4.3B | $3.7B | $4B | |
| Gross Profit | $99.1M | $142.9M | $351.7M | $451.7M | $230.8M | |
| Gross Profit Margin | 4.37% | 4.54% | 7.51% | 10.8% | 5.51% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $138.9M | $203.9M | $197.3M | $187.9M | $201.2M | |
| Other Inc / (Exp) | $43.1M | -$27.6M | -$126.6M | $700K | $5.4M | |
| Operating Expenses | $164.2M | $224.4M | $219.1M | $181M | $220.7M | |
| Operating Income | -$65.1M | -$81.5M | $132.6M | $270.7M | $10.1M | |
| Net Interest Expenses | $125.9M | $149.5M | $175.9M | $221.7M | $236.7M | |
| EBT. Incl. Unusual Items | -$147.9M | -$258.6M | -$169.9M | $49.7M | -$221.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1M | $1.5M | $3.4M | $1.6M | $800K | |
| Net Income to Company | -$149M | -$260.1M | -$173.3M | $48.1M | -$222M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$149M | -$260.1M | -$173.3M | $48.1M | -$222M | |
| Basic EPS (Cont. Ops) | -$1.86 | -$3.23 | -$2.14 | $0.59 | -$2.67 | |
| Diluted EPS (Cont. Ops) | -$1.86 | -$3.23 | -$2.14 | $0.59 | -$2.67 | |
| Weighted Average Basic Share | $78.4M | $79M | $79.3M | $80.1M | $83.1M | |
| Weighted Average Diluted Share | $78.4M | $79M | $79.3M | $80.1M | $83.1M | |
| EBITDA | $83.1M | -$1.4M | $104.3M | $418.2M | $164.5M | |
| EBIT | -$22M | -$109.1M | $6M | $271.4M | $15.5M | |
| Revenue (Reported) | $2.3B | $3.1B | $4.7B | $4.2B | $4.2B | |
| Operating Income (Reported) | -$65.1M | -$81.5M | $132.6M | $270.7M | $10.1M | |
| Operating Income (Adjusted) | -$22M | -$109.1M | $6M | $271.4M | $15.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $600.3M | $1.1B | $1B | $1B | $993.9M | |
| Revenue Growth (YoY) | -13.33% | 82.89% | -5.52% | -3.04% | -1.18% | |
| Cost of Revenues | $642.3M | $1.1B | $940.7M | $927.3M | $1.1B | |
| Gross Profit | -$42M | $32.7M | $96.6M | $78.5M | -$81.4M | |
| Gross Profit Margin | -7% | 2.98% | 9.31% | 7.81% | -8.19% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $49.8M | $45.2M | $50.6M | $37M | $24.4M | |
| Other Inc / (Exp) | -$5M | -$25.9M | $25.3M | -$16.9M | $7.8M | |
| Operating Expenses | $64.7M | $50M | $53.6M | $42.2M | $29.5M | |
| Operating Income | -$106.7M | -$17.3M | $43M | $36.3M | -$110.9M | |
| Net Interest Expenses | $34.2M | $51.6M | $49.2M | $60.8M | $58.5M | |
| EBT. Incl. Unusual Items | -$145.9M | -$94.8M | $19.1M | -$41.4M | -$161.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $200K | $700K | $500K | $200K | $400K | |
| Net Income to Company | -$146.1M | -$95.5M | $18.6M | -$41.6M | -$162M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$146.1M | -$95.5M | $18.6M | -$41.6M | -$162M | |
| Basic EPS (Cont. Ops) | -$1.82 | -$1.18 | $0.23 | -$0.51 | -$1.87 | |
| Diluted EPS (Cont. Ops) | -$1.82 | -$1.18 | $0.23 | -$0.51 | -$1.87 | |
| Weighted Average Basic Share | $78.6M | $79.1M | $79.8M | $80.4M | $86.4M | |
| Weighted Average Diluted Share | $78.6M | $79.1M | $79.9M | $80.4M | $86.4M | |
| EBITDA | -$111.7M | -$43.2M | $68.3M | $19.4M | -$103.1M | |
| EBIT | -$111.7M | -$43.2M | $68.3M | $19.4M | -$103.1M | |
| Revenue (Reported) | $600.3M | $1.1B | $1B | $1B | $993.9M | |
| Operating Income (Reported) | -$106.7M | -$17.3M | $43M | $36.3M | -$110.9M | |
| Operating Income (Adjusted) | -$111.7M | -$43.2M | $68.3M | $19.4M | -$103.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $3.6B | $4.6B | $4.1B | $4.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.1B | $3.4B | $4.2B | $3.7B | $4.1B | |
| Gross Profit | $33.6M | $217.6M | $415.6M | $433.6M | $70.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $155.2M | $199.3M | $202.7M | $174.3M | $188.6M | |
| Other Inc / (Exp) | -$1.3M | -$48.5M | -$75.4M | -$41.5M | $30.1M | |
| Operating Expenses | $181.4M | $209.7M | $222.7M | $169.6M | $208M | |
| Operating Income | -$147.8M | $7.9M | $192.9M | $264M | -$137.1M | |
| Net Interest Expenses | $130.8M | $166.9M | $173.5M | $233.3M | $234.4M | |
| EBT. Incl. Unusual Items | -$279.9M | -$207.5M | -$56M | -$10.8M | -$341.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $800K | $2M | $3.2M | $1.3M | $1M | |
| Net Income to Company | -$280.7M | -$209.5M | -$59.2M | -$12.1M | -$342.4M | |
| Minority Interest in Earnings | -- | -- | $1.1M | -- | -- | |
| Net Income to Common Excl Extra Items | -$280.7M | -$209.5M | -$59M | -$12.1M | -$342.4M | |
| Basic EPS (Cont. Ops) | -$3.50 | -$2.59 | -$0.63 | -$0.13 | -$4.00 | |
| Diluted EPS (Cont. Ops) | -$3.50 | -$2.59 | -$0.63 | -$0.13 | -$4.00 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$149.1M | -$40.6M | $117.5M | $222.5M | -$107M | |
| EBIT | -$149.1M | -$40.6M | $117.5M | $222.5M | -$107M | |
| Revenue (Reported) | $2.2B | $3.6B | $4.6B | $4.1B | $4.2B | |
| Operating Income (Reported) | -$147.8M | $7.9M | $192.9M | $264M | -$137.1M | |
| Operating Income (Adjusted) | -$149.1M | -$40.6M | $117.5M | $222.5M | -$107M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $600.3M | $1.1B | $1B | $1B | $993.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $642.3M | $1.1B | $940.7M | $927.3M | $1.1B | |
| Gross Profit | -$42M | $32.7M | $96.6M | $78.5M | -$81.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $49.8M | $45.2M | $50.6M | $37M | $24.4M | |
| Other Inc / (Exp) | -$5M | -$25.9M | $25.3M | -$16.9M | $7.8M | |
| Operating Expenses | $64.7M | $50M | $53.6M | $42.2M | $29.5M | |
| Operating Income | -$106.7M | -$17.3M | $43M | $36.3M | -$110.9M | |
| Net Interest Expenses | $34.2M | $51.6M | $49.2M | $60.8M | $58.5M | |
| EBT. Incl. Unusual Items | -$145.9M | -$94.8M | $19.1M | -$41.4M | -$161.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $200K | $700K | $500K | $200K | $400K | |
| Net Income to Company | -$146.1M | -$95.5M | $18.6M | -$41.6M | -$162M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$146.1M | -$95.5M | $18.6M | -$41.6M | -$162M | |
| Basic EPS (Cont. Ops) | -$1.82 | -$1.18 | $0.23 | -$0.51 | -$1.87 | |
| Diluted EPS (Cont. Ops) | -$1.82 | -$1.18 | $0.23 | -$0.51 | -$1.87 | |
| Weighted Average Basic Share | $78.6M | $79.1M | $79.8M | $80.4M | $86.4M | |
| Weighted Average Diluted Share | $78.6M | $79.1M | $79.9M | $80.4M | $86.4M | |
| EBITDA | -$111.7M | -$43.2M | $68.3M | $19.4M | -$103.1M | |
| EBIT | -$111.7M | -$43.2M | $68.3M | $19.4M | -$103.1M | |
| Revenue (Reported) | $600.3M | $1.1B | $1B | $1B | $993.9M | |
| Operating Income (Reported) | -$106.7M | -$17.3M | $43M | $36.3M | -$110.9M | |
| Operating Income (Adjusted) | -$111.7M | -$43.2M | $68.3M | $19.4M | -$103.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $109.4M | $38.1M | $35.2M | $7.9M | $38.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $152.4M | $216.8M | $244.7M | $252.4M | $241.7M | |
| Inventory | $254.9M | $326.6M | $497.7M | $439.4M | $416.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $10.2M | $14.9M | $19.6M | $51.6M | $33.5M | |
| Total Current Assets | $534.9M | $632.6M | $819.6M | $794.7M | $766M | |
| Property Plant And Equipment | $1B | $1.1B | $1.6B | $1.6B | $1.7B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $173M | $173M | $173M | $173M | $173M | |
| Other Intangibles | $57.6M | $45.8M | $36.3M | $28.5M | $22M | |
| Other Long-Term Assets | $37.2M | $169.1M | $122.6M | $134.4M | $118.2M | |
| Total Assets | $1.8B | $2.1B | $2.7B | $2.8B | $2.8B | |
| Accounts Payable | $179.3M | $301M | $442M | $322M | $320.8M | |
| Accrued Expenses | $59.3M | $121.4M | $127.6M | $135.8M | $140.1M | |
| Current Portion Of Long-Term Debt | $2.3M | $6.6M | $19.6M | $55.7M | $35.5M | |
| Current Portion Of Capital Lease Obligations | $42M | $65.9M | $70.7M | $75.6M | $58.8M | |
| Other Current Liabilities | $252.1M | $393.3M | $681.5M | $510.1M | $296.5M | |
| Total Current Liabilities | $544.5M | $899.8M | $1.4B | $1.1B | $863.6M | |
| Long-Term Debt | $1.3B | $1.4B | $1.5B | $1.8B | $2.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9B | $2.5B | $3B | $3B | $3.2B | |
| Common Stock | -- | -- | -- | -- | $900K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$128.6M | -$385.1M | -$533.3M | -- | -$704.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $245.6M | $245.6M | $245.6M | |
| Total Equity | -$128.6M | -$385.1M | -$287.7M | -$244.7M | -$466.3M | |
| Total Liabilities and Equity | $1.8B | $2.1B | $2.7B | $2.8B | $2.8B | |
| Cash and Short Terms | $109.4M | $38.1M | $35.2M | $7.9M | $38.1M | |
| Total Debt | $1.3B | $1.4B | $1.6B | $1.9B | $2.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $114.2M | $10.7M | $11.2M | $23.9M | $123.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $198.6M | $306.1M | $262.2M | $289.4M | $281.4M | |
| Inventory | $257.8M | $337.6M | $454.8M | $403.1M | $389.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $11.3M | $10.8M | $29.9M | $40.2M | $21.9M | |
| Total Current Assets | $602.6M | $691.8M | $799.9M | $811.7M | $917.9M | |
| Property Plant And Equipment | $904.9M | $1B | $1.5B | $1.5B | $1.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $360.5M | $488.6M | $421.4M | $433.9M | $492.8M | |
| Total Assets | $1.9B | $2.2B | $2.8B | $2.7B | $2.8B | |
| Accounts Payable | $203.9M | $415.1M | $394.3M | $321.1M | $306.1M | |
| Accrued Expenses | $92.8M | $98.5M | $114.6M | $109.7M | $81.6M | |
| Current Portion Of Long-Term Debt | -- | -- | $20.6M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $162.7M | $595.3M | $736.2M | $367.3M | $457.5M | |
| Total Current Liabilities | $831.7M | $1.1B | $1.3B | $824.4M | $869.1M | |
| Long-Term Debt | $1.2B | $1.4B | $1.7B | $2.1B | $2.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.1B | $2.7B | $3B | $3B | $3.4B | |
| Common Stock | -- | -- | -- | -- | $900K | |
| Other Common Equity Adj | -- | -- | -- | -- | -$7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $250M | $245.6M | $245.6M | |
| Total Equity | -$273.5M | -$463.8M | -$276.1M | -$284.1M | -$616.7M | |
| Total Liabilities and Equity | $1.9B | $2.2B | $2.8B | $2.7B | $2.8B | |
| Cash and Short Terms | $114.2M | $10.7M | $11.2M | $23.9M | $123.4M | |
| Total Debt | $1.4B | $1.4B | $1.7B | $2.1B | $2.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$149M | -$260.1M | -$173.3M | $48.1M | -$222M | |
| Depreciation & Amoritzation | $105.1M | $107.7M | $98.3M | $146.8M | $149M | |
| Stock-Based Compensation | $5.5M | $50.7M | $17.3M | $14.7M | $14.6M | |
| Change in Accounts Receivable | $25.5M | -$91.4M | -$14.1M | -$19.2M | $8M | |
| Change in Inventories | $14M | -$27M | -$190.5M | $25.1M | $16.1M | |
| Cash From Operations | $62.8M | -$44M | $100.6M | -$14.9M | -$46.4M | |
| Capital Expenditures | $44M | $82.9M | $536.2M | $271.8M | $76.7M | |
| Cash Acquisitions | -$3.3M | -- | -- | -- | -- | |
| Cash From Investing | -$46.3M | -$82.8M | -$536M | -$271.8M | -$76.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | $1.4B | $2B | $2.6B | $2.8B | |
| Long-Term Debt Repaid | -$1B | -$1.4B | -$2.3B | -$2.4B | -$2.7B | |
| Repurchase of Common Stock | -- | -- | -$4.4M | -- | -- | |
| Other Financing Activities | -$33.7M | $97.9M | $635.4M | $17.5M | $56.6M | |
| Cash From Financing | $73.8M | $139.3M | $348.7M | $266.2M | $154.3M | |
| Beginning Cash (CF) | $19.1M | $109.4M | $121.9M | $35.2M | $14.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $90.3M | $12.5M | -$86.7M | -$20.5M | $31.2M | |
| Ending Cash (CF) | $109.4M | $121.9M | $35.2M | $14.7M | $45.9M | |
| Levered Free Cash Flow | $18.8M | -$126.9M | -$435.6M | -$286.7M | -$123.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$146.1M | -$95.5M | $18.6M | -$41.6M | -$162M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$50.3M | -$2.9M | -$26.7M | -$94M | -$110.6M | |
| Capital Expenditures | $6.2M | $67.2M | $130.4M | $20M | $17.6M | |
| Cash Acquisitions | -- | -- | -- | -- | $95.4M | |
| Cash From Investing | -$6.2M | -$67M | -$130.4M | -$20M | $77.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $216.1M | $590M | $577.7M | $828.8M | $1.7B | |
| Long-Term Debt Repaid | -$208.6M | -$579M | -$437M | -$625M | -$1.5B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $53.8M | -$8.4M | -$7.6M | -$73.1M | -$16.8M | |
| Cash From Financing | $61.3M | $2.6M | $133.1M | $130.7M | $190.3M | |
| Beginning Cash (CF) | $109.4M | $121.9M | $35.2M | $14.7M | $45.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.8M | -$67.3M | -$24M | $16.7M | $157.5M | |
| Ending Cash (CF) | $114.2M | $54.6M | $11.2M | $31.4M | $203.4M | |
| Levered Free Cash Flow | -$56.5M | -$70.1M | -$157.1M | -$114M | -$128.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$280.7M | -$209.5M | -$59.2M | -$12.1M | -$342.4M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $32.4M | $3.4M | $76.8M | -$82.2M | -$63M | |
| Capital Expenditures | $35.3M | $143.9M | $599.4M | $161.4M | $74.3M | |
| Cash Acquisitions | -- | -- | -- | -- | $95.4M | |
| Cash From Investing | -$35.2M | -$143.6M | -$599.4M | -$161.4M | $21.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $874.3M | $1.8B | $2B | $2.9B | $3.8B | |
| Long-Term Debt Repaid | -$906.5M | -$1.8B | -$2.2B | -$2.5B | -$3.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $45.5M | $35.7M | $636.2M | -$48M | $112.9M | |
| Cash From Financing | $13.3M | $80.6M | $479.2M | $263.8M | $213.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $10.5M | -$59.6M | -$43.4M | $20.2M | $172M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$2.9M | -$140.5M | -$522.6M | -$243.6M | -$137.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$146.1M | -$95.5M | $18.6M | -$41.6M | -$162M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$50.3M | -$2.9M | -$26.7M | -$94M | -$110.6M | |
| Capital Expenditures | $6.2M | $67.2M | $130.4M | $20M | $17.6M | |
| Cash Acquisitions | -- | -- | -- | -- | $95.4M | |
| Cash From Investing | -$6.2M | -$67M | -$130.4M | -$20M | $77.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $216.1M | $590M | $577.7M | $828.8M | $1.7B | |
| Long-Term Debt Repaid | -$208.6M | -$579M | -$437M | -$625M | -$1.5B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $53.8M | -$8.4M | -$7.6M | -$73.1M | -$16.8M | |
| Cash From Financing | $61.3M | $2.6M | $133.1M | $130.7M | $190.3M | |
| Beginning Cash (CF) | $109.4M | $121.9M | $35.2M | $14.7M | $45.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.8M | -$67.3M | -$24M | $16.7M | $157.5M | |
| Ending Cash (CF) | $114.2M | $54.6M | $11.2M | $31.4M | $203.4M | |
| Levered Free Cash Flow | -$56.5M | -$70.1M | -$157.1M | -$114M | -$128.2M | |
Get CLMT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLMT
Sector
P/E ratio
--
11.50x
PEG ratio
0.00x
0.01x
P/B ratio
--
1.01x
Price / LTM sales
0.33x
0.85x
Growth Metrics
CLMT
Sector
Revenue growth
-1.18%
-0.23%
Earnings growth
--
-9.79%
Revenue (5-year growth)
3.94%
6.13%
Earnings forecast
-$0.16
$0.20
Profitability
CLMT
Sector
Profitability FY 2024
$230.8M
$92.9M
Return on invested capital
-17.89%
3.61%
Return on assets
-12.57%
2.38%
Return on equity
--
5.96%
Earnings Date
Last Earnings Date
May
9
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
8
Balance Sheet
CLMT
Sector
Total cash
$123.4M
$12.9M
Short term investments
--
$2.9M
Total assets
$2.8B
$380.4M
Long term debt
$2.3B
$122.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
